Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
NCT00579566 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2025-07-30
Summary
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
Conditions
- Sarcoma
Interventions
- OTHER
-
Specimen protocol
The research specimen will be obtained from the residual specimen that would otherwise be discarded per usual hospital procedure.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Singer Singer, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
NCT01585376 ·Status: COMPLETED
-
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
NCT00919269 ·Status: COMPLETED
-
Circulating Tumor DNA in Soft Tissue Sarcoma
NCT03818412 ·Status: RECRUITING ·Phase: NA
-
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
NCT02199938 ·Status: TERMINATED
-
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
NCT01802125 ·Status: COMPLETED
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
NCT03896620 ·Status: RECRUITING
-
Biomarkers in Patients With Advanced Rhabdomyosarcoma
NCT01668095 ·Status: COMPLETED
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma
NCT01419509 ·Status: COMPLETED
-
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
NCT01365949 ·Status: COMPLETED
-
Quantitative MR Biomarkers for Sarcoma Treatment
NCT01017978 ·Status: COMPLETED ·Phase: NA
-
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
NCT00579930 ·Status: COMPLETED
-
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
NCT01426945 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Molecular Analysis Of Solid Tumors
NCT01050296 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
NCT01480518 ·Status: COMPLETED
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
NCT00588068 ·Status: RECRUITING
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
NCT01433237 ·Status: COMPLETED
-
Skin Tumor Biomarkers by Mass Spectrometry Imaging
NCT06227416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA